• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents.

作者信息

Steiner Thorsten, Weitz Jeffrey I, Veltkamp Roland

机构信息

From the Department of Neurology, Klinikum Frankfurt Höchst, Germany (T.S.); Department of Neurology, Heidelberg University Hospital, Germany (T.S., R.V.); Thrombosis and Atherosclerosis Research Institute and the Departments of Medicine and Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada (J.I.W.); and Department of Stroke, Medicine, Imperial College, London, United Kingdom (R.V.).

出版信息

Stroke. 2017 May;48(5):1432-1437. doi: 10.1161/STROKEAHA.116.013343. Epub 2017 Apr 11.

DOI:10.1161/STROKEAHA.116.013343
PMID:28400486
Abstract
摘要

相似文献

1
Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents.逆转剂时代的抗凝相关颅内出血
Stroke. 2017 May;48(5):1432-1437. doi: 10.1161/STROKEAHA.116.013343. Epub 2017 Apr 11.
2
Treatment of intracerebral hemorrhage associated with new oral anticoagulant use: the neurologist's view.新型口服抗凝药相关脑出血的治疗：神经科医生的观点
Clin Lab Med. 2014 Sep;34(3):587-94. doi: 10.1016/j.cll.2014.06.007. Epub 2014 Jul 29.
3
Reversal of anticoagulant effects in patients with intracerebral hemorrhage.脑出血患者抗凝作用的逆转。
Curr Neurol Neurosci Rep. 2015 Jan;15(1):504. doi: 10.1007/s11910-014-0504-2.
4
[First new oral anticoagulant with specific antidote].[首款具有特异性解毒剂的新型口服抗凝药]
MMW Fortschr Med. 2016 Mar 17;158(5):73. doi: 10.1007/s15006-016-7952-3.
5
Medical Treatment for Spontaneous Anticoagulation-Related Intracerebral Hemorrhage in the Netherlands.荷兰自发性抗凝相关脑出血的医学治疗
J Stroke Cerebrovasc Dis. 2017 Jul;26(7):1427-1432. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.019. Epub 2017 Apr 12.
6
Anticoagulant-associated intracerebral hemorrhage.抗凝相关脑出血。
Semin Neurol. 2010 Nov;30(5):565-72. doi: 10.1055/s-0030-1268866. Epub 2011 Jan 4.
7
Reversal of antithrombotic agents.抗血栓药物的逆转。
Am J Hematol. 2012 May;87 Suppl 1:S119-26. doi: 10.1002/ajh.23165. Epub 2012 Mar 28.
8
Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant.依达赛珠单抗（Praxbind）：首款用于直接口服抗凝剂的逆转剂。
Am J Med. 2017 May;130(5):e195-e197. doi: 10.1016/j.amjmed.2016.11.029. Epub 2016 Dec 21.
9
The role of anticoagulants, antiplatelet agents, and their reversal strategies in the management of intracerebral hemorrhage.抗凝剂、抗血小板药物及其逆转策略在脑出血管理中的作用。
Neurosurg Focus. 2013 May;34(5):E6. doi: 10.3171/2013.2.FOCUS1328.
10
Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.争分夺秒：克服抗凝相关脑出血管理中的挑战。
J Neurosurg. 2014 Aug;121 Suppl:1-20. doi: 10.3171/2014.8.paradigm.

引用本文的文献

1
Management and Outcomes of Intracranial Hemorrhage in Atrial Fibrillation Patients: Highlighting Practices in Saudi Arabia.心房颤动患者颅内出血的管理与结局：聚焦沙特阿拉伯的实践
Cureus. 2025 Apr 22;17(4):e82813. doi: 10.7759/cureus.82813. eCollection 2025 Apr.
2
Principles of reversal of anticoagulation in patients with intracerebral hemorrhage related to oral anticoagulants.与口服抗凝药相关的脑出血患者抗凝逆转的原则
Eur Stroke J. 2025 Apr;10(1_suppl):4-13. doi: 10.1177/23969873231222393. Epub 2025 May 22.
3
Reversal of anticoagulation in patients with intracerebral haemorrhage related to oral anticoagulants: State of the evidence.
口服抗凝剂相关脑出血患者抗凝的逆转：证据现状
Eur Stroke J. 2025 Apr;10(1_suppl):14-23. doi: 10.1177/23969873241281477. Epub 2025 May 22.
4
Economic burden of disease and mortality of intracranial haemorrhage under oral FXai: a German claims data analysis.口服直接Xa因子抑制剂治疗下颅内出血的疾病经济负担和死亡率：一项德国索赔数据分析
Neurol Res Pract. 2025 Mar 31;7(1):21. doi: 10.1186/s42466-025-00366-3.
5
Reversal of oral anticoagulation in emergency conditions.紧急情况下口服抗凝治疗的逆转
Blood Transfus. 2025 Jan;23(1):64-69. doi: 10.2450/BloodTransfus.993. Epub 2025 Jan 22.
6
Reversal treatment and clinical outcomes in acute intracranial haemorrhage associated with oral anticoagulant use: protocol of a planned systematic review and meta-analysis.与口服抗凝剂使用相关的急性颅内出血的逆转治疗及临床结局：一项计划中的系统评价和荟萃分析方案
BMJ Open. 2025 Feb 18;15(2):e090357. doi: 10.1136/bmjopen-2024-090357.
7
The Applicability of Novel Predictor of Intracranial Hemorrhage in Patients With Atrial Fibrillation in the Contemporary Real-World Clinical Practice.新型颅内出血预测指标在当代真实世界临床实践中对房颤患者的适用性
Clin Cardiol. 2025 Jan;48(1):e70078. doi: 10.1002/clc.70078.
8
Should We Give Antithrombotic Therapy to Patients With Infective Endocarditis?: A Serious Question, But Unresolved.我们应该给感染性心内膜炎患者进行抗栓治疗吗？：一个严肃的问题，但尚未解决。
JACC Adv. 2023 Dec 19;3(2):100766. doi: 10.1016/j.jacadv.2023.100766. eCollection 2024 Feb.
9
Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage.四因子凝血酶原复合物浓缩剂与andexanet alfa联合使用以逆转非创伤性颅内出血。
Hosp Pharm. 2024 Aug;59(4):394-406. doi: 10.1177/00185787241229192. Epub 2024 Feb 16.
10
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Cancer: A Target Trial Emulation from SEER-Medicare Database.直接口服抗凝剂与华法林在房颤合并癌症患者中的有效性和安全性：一项基于SEER - 医疗保险数据库的目标试验模拟研究
Cardiovasc Drugs Ther. 2024 Jun 7. doi: 10.1007/s10557-024-07589-7.